These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer. Kelenis DP; Rodarte KE; Kollipara RK; Pozo K; Choudhuri SP; Spainhower KB; Wait SJ; Stastny V; Oliver TG; Johnson JE Cancer Res; 2022 Sep; 82(17):3058-3073. PubMed ID: 35748745 [TBL] [Abstract][Full Text] [Related]
3. ASCL1 and NEUROD1 Reveal Heterogeneity in Pulmonary Neuroendocrine Tumors and Regulate Distinct Genetic Programs. Borromeo MD; Savage TK; Kollipara RK; He M; Augustyn A; Osborne JK; Girard L; Minna JD; Gazdar AF; Cobb MH; Johnson JE Cell Rep; 2016 Aug; 16(5):1259-1272. PubMed ID: 27452466 [TBL] [Abstract][Full Text] [Related]
4. Distinct transcriptional programs of SOX2 in different types of small cell lung cancers. Tenjin Y; Matsuura K; Kudoh S; Usuki S; Yamada T; Matsuo A; Sato Y; Saito H; Fujino K; Wakimoto J; Ichimura T; Kohrogi H; Sakagami T; Niwa H; Ito T Lab Invest; 2020 Dec; 100(12):1575-1588. PubMed ID: 32801334 [TBL] [Abstract][Full Text] [Related]
5. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology. Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131 [TBL] [Abstract][Full Text] [Related]
6. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small-cell lung cancer: an international multicenter study. Megyesfalvi Z; Barany N; Lantos A; Valko Z; Pipek O; Lang C; Schwendenwein A; Oberndorfer F; Paku S; Ferencz B; Dezso K; Fillinger J; Lohinai Z; Moldvay J; Galffy G; Szeitz B; Rezeli M; Rivard C; Hirsch FR; Brcic L; Popper H; Kern I; Kovacevic M; Skarda J; Mittak M; Marko-Varga G; Bogos K; Renyi-Vamos F; Hoda MA; Klikovits T; Hoetzenecker K; Schelch K; Laszlo V; Dome B J Pathol; 2022 Aug; 257(5):674-686. PubMed ID: 35489038 [TBL] [Abstract][Full Text] [Related]
7. Significance of achaete-scute complex homologue 1 (ASCL1) in pulmonary neuroendocrine carcinomas; RNA sequence analyses using small cell lung cancer cells and Ascl1-induced pulmonary neuroendocrine carcinoma cells. Kudoh S; Tenjin Y; Kameyama H; Ichimura T; Yamada T; Matsuo A; Kudo N; Sato Y; Ito T Histochem Cell Biol; 2020 Jun; 153(6):443-456. PubMed ID: 32170367 [TBL] [Abstract][Full Text] [Related]
8. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer. Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560 [TBL] [Abstract][Full Text] [Related]
9. Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer. Chen C; Breslin MB; Lan MS Cell Signal; 2018 Jun; 46():83-91. PubMed ID: 29501727 [TBL] [Abstract][Full Text] [Related]
10. Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers. Qu S; Fetsch P; Thomas A; Pommier Y; Schrump DS; Miettinen MM; Chen H J Thorac Oncol; 2022 Jan; 17(1):141-153. PubMed ID: 34534680 [TBL] [Abstract][Full Text] [Related]
11. The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis. Oser MG; Sabet AH; Gao W; Chakraborty AA; Schinzel AC; Jennings RB; Fonseca R; Bonal DM; Booker MA; Flaifel A; Novak JS; Christensen CL; Zhang H; Herbert ZT; Tolstorukov MY; Buss EJ; Wong KK; Bronson RT; Nguyen QD; Signoretti S; Kaelin WG Genes Dev; 2019 Dec; 33(23-24):1718-1738. PubMed ID: 31727771 [TBL] [Abstract][Full Text] [Related]
12. NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration. Ikematsu Y; Tanaka K; Toyokawa G; Ijichi K; Ando N; Yoneshima Y; Iwama E; Inoue H; Tagawa T; Nakanishi Y; Okamoto I Lung Cancer; 2020 Aug; 146():97-104. PubMed ID: 32526603 [TBL] [Abstract][Full Text] [Related]
14. POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Huang YH; Klingbeil O; He XY; Wu XS; Arun G; Lu B; Somerville TDD; Milazzo JP; Wilkinson JE; Demerdash OE; Spector DL; Egeblad M; Shi J; Vakoc CR Genes Dev; 2018 Jul; 32(13-14):915-928. PubMed ID: 29945888 [TBL] [Abstract][Full Text] [Related]
15. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1. Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690 [TBL] [Abstract][Full Text] [Related]
16. Promoters of ASCL1- and NEUROD1-dependent genes are specific targets of lurbinectedin in SCLC cells. Costanzo F; Martínez Diez M; Santamaría Nuñez G; Díaz-Hernandéz JI; Genes Robles CM; Díez Pérez J; Compe E; Ricci R; Li TK; Coin F; Martínez Leal JF; Garrido-Martin EM; Egly JM EMBO Mol Med; 2022 Apr; 14(4):e14841. PubMed ID: 35263037 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer. Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890 [TBL] [Abstract][Full Text] [Related]
18. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Augustyn A; Borromeo M; Wang T; Fujimoto J; Shao C; Dospoy PD; Lee V; Tan C; Sullivan JP; Larsen JE; Girard L; Behrens C; Wistuba II; Xie Y; Cobb MH; Gazdar AF; Johnson JE; Minna JD Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14788-93. PubMed ID: 25267614 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity of Small Cell Lung Cancer to BET Inhibition Is Mediated by Regulation of ASCL1 Gene Expression. Lenhart R; Kirov S; Desilva H; Cao J; Lei M; Johnston K; Peterson R; Schweizer L; Purandare A; Ross-Macdonald P; Fairchild C; Wong T; Wee S Mol Cancer Ther; 2015 Oct; 14(10):2167-74. PubMed ID: 26253517 [TBL] [Abstract][Full Text] [Related]
20. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization. Baine MK; Hsieh MS; Lai WV; Egger JV; Jungbluth AA; Daneshbod Y; Beras A; Spencer R; Lopardo J; Bodd F; Montecalvo J; Sauter JL; Chang JC; Buonocore DJ; Travis WD; Sen T; Poirier JT; Rudin CM; Rekhtman N J Thorac Oncol; 2020 Dec; 15(12):1823-1835. PubMed ID: 33011388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]